Literature DB >> 25309081

Review of experimental attempts of islet allotransplantation in rodents: parameters involved and viability of the procedure.

Leandro Ryuchi Iuamoto1, Alberto Meyer1, Eleazar Chaib1, Luiz Augusto Carneiro D'Albuquerque1.   

Abstract

The purpose of the present study was to organize the parameters involved in experimental allotransplantation in rodents to elaborate the most suitable model to supply the scarcity of islet donors. We used the PubMed database to systematically search for published articles containing the keywords "rodent islet transplantation" to review. We included studies that involved allotransplantation experiments with rodents' islets, and we reviewed the reference lists from the eligible publications that were retrieved. We excluded articles related to isotransplantation, autotransplantation and xenotransplantation, i.e., transplantation in other species. A total of 25 studies related to allotransplantation were selected for systematic review based on their relevance and updated data. Allotransplantation in rodents is promising and continues to develop. Survival rates of allografts have increased with the discovery of new immunosuppressive drugs and the use of different graft sites. These successes suggest that islet transplantation is a promising method to overcome the scarcity of islet donors and advance the treatment options for type 1 diabetes.

Entities:  

Keywords:  Allograft; Diabetes mellitus; Hyperglycemia; Immunosuppression; Islet; Islet grafts; Islet transplantation; Type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25309081      PMCID: PMC4188902          DOI: 10.3748/wjg.v20.i37.13512

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  In vivo test of two low doses of mycophenolate mofetil in an experimental model of islet allotransplantation.

Authors:  P Xekouki; A Papalois; C Fotiadis; J Sfiniadakis; E Karampela; A Papadopoulou; Th Grigoriou; M N Sechas
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

2.  Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats.

Authors:  Constantin Fotiadis; Paraskevi Xekouki; Apostolos E Papalois; Pantelis T Antonakis; Ioannis Sfiniadakis; Dimitrios Flogeras; Eleutheria Karampela; George Zografos
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  Inhibition of allospecific response in pancreatic islet transplantation: the glycan approach.

Authors:  M Vieiro; C Ceballos; P Barrionuevo; S H Hyon; M Isturiz; P Argibay
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

4.  Successful single donor islet allotransplantation in the streptozotocin diabetes rat model.

Authors:  Henning Jahr; Birte Hussmann; Torsten Eckhardt; Reinhard G Bretzel
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

5.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors:  A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

6.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

7.  Importance of hyperglycemia on the primary function of allogeneic islet transplants.

Authors:  Leila Makhlouf; Valérie F Duvivier-Kali; Susan Bonner-Weir; Hans Dieperink; Gordon C Weir; Mohamed H Sayegh
Journal:  Transplantation       Date:  2003-08-27       Impact factor: 4.939

8.  Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species.

Authors:  Xiaoyan Li; Hainan Chen; Paul N Epstein
Journal:  J Biol Chem       Date:  2003-10-23       Impact factor: 5.157

9.  Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance.

Authors:  Masaaki Watanabe; Kenichiro Yamashita; Hirofumi Kamachi; Daisuke Kuraya; Yasuyuki Koshizuka; Susumu Shibasaki; Yoh Asahi; Hitoshi Ono; Shin Emoto; Masaomi Ogura; Tadashi Yoshida; Michitaka Ozaki; Kazuo Umezawa; Michiaki Matsushita; Satoru Todo
Journal:  Transplantation       Date:  2013-09-15       Impact factor: 4.939

10.  Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.

Authors:  Marshall S Baker; Xiaojuan Chen; Alizah R Rotramel; Jeffrey J Nelson; Bao Lu; Craig Gerard; Yashpal Kanwar; Dixon B Kaufman
Journal:  Surgery       Date:  2003-08       Impact factor: 3.982

View more
  2 in total

Review 1.  Human islet xenotransplantation in rodents: A literature review of experimental model trends.

Authors:  Leandro Ryuchi Iuamoto; André Silva Franco; Fábio Yuji Suguita; Felipe Futema Essu; Lucas Torres Oliveira; Juliana Mika Kato; Matheus Belloni Torsani; Alberto Meyer; Wellington Andraus; Eleazar Chaib; Luiz Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2017-04       Impact factor: 2.365

2.  Gastric fundus submucosa as a site for islets transplantation: An experimental study.

Authors:  Gustavo Heluani Antunes de Mesquita; Yuri Justi Jardim; Leandro Ryuchi Iuamoto; Fabio Yuji Suguita; Felipe Futema Essu; Lucas Torres Oliveira; Alberto Meyer; Alessandra Crescenzi; Vinícius Rocha-Santos; Flavio H F Galvão; Wellington Andraus; Eleazar Chaib; Luiz Augusto Carneiro D'Albuquerque
Journal:  Ann Med Surg (Lond)       Date:  2018-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.